PCSK9 monoclonal antibody on a knife-edge: An article of faith in FH?

- Commentary on use of PCSK9 monoclonal antibodies in familial hypercholesterolemia.
- Comment on recent analysis from the SPIRE clinical trial program.
- Future treatment options in patients with familial hypercholesterolemia.